06/12/2025
Why Patient-Reported Outcomes Are Key to Advancing Women’s Health
This recent article in Pharma Times highlights the importance of patient reported outcomes in pharma research https://magazine.pharmatimes.com/collections/37023148-095f-11f0-972e-42010a800019-3el5/380b39f7-095f-11f0-972e-42010a800019-kfxk?fullscreen=false
Women—particularly those who are pregnant or breastfeeding—have historically been underrepresented in clinical trials. This has left significant gaps in our understanding of how treatments affect women across different life stages and health conditions.
Patient-reported outcomes (PROs) are essential. They capture the real-world impact of treatments—symptoms, side effects, and quality of life—directly from the patient’s perspective. Yet, without robust participation from women, especially during pregnancy and lactation, we miss out on valuable insights that could lead to safer, more effective care.
Positive change is underway:
âś” Inclusive trial designs are making it easier for women to participate, reducing the burden and increasing accessibility.
✔ Patient input tools and engagement strategies are ensuring that women’s voices are heard from the earliest stages of research.
âś” Collaboration among industry, regulators, and advocacy groups is driving progress toward more representative data and better health outcomes.
The spectre, the shadow, the shock to the system! Yes, folks, this time we are focussing on the accumulation of humanity’s biggest dreams and worst nightmares. It’s AI time! And we’re talking about AI healthcare, AI public health, AI hospitals, AI pharma and AI patients. It’s the force of ne...